Cost-Consequence Analysis of Using Neurofarmagen In The Decision-Making Process During The Treatment of Patients With Depression In The U.S
Abstract
Authors
J Espadaler D Carcedo A Pérez-Mitru J Menchón J Saiz-Ruiz J Bobes E Vieta E Alvarez V Pérez